Beijing Yuance Pharmaceutical

Beijing Yuance Pharmaceutical, commonly known as YuceBio, is a biotechnology company specializing in precision oncology and personalized immunotherapy. The company integrates advanced next-generation sequencing (NGS) diagnostics with the development of neoantigen-based cancer vaccines and cell therapies. By utilizing proprietary bioinformatics algorithms and big data, Yuance identifies patient-specific tumor mutations to design tailored therapeutic interventions. Their lead programs include personalized neoantigen vaccines currently undergoing clinical evaluation in various solid tumors. The company aims to provide a comprehensive precision medicine solution that spans from genomic testing to targeted immunotherapy.